Multivessel Coronary Artery Disease
34
5
6
11
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.9%
1 terminated out of 34 trials
91.7%
+5.2% vs benchmark
12%
4 trials in Phase 3/4
27%
3 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (34)
Brazilian Prospective Registry of the Inspiron EVO Drug-Eluting Stent in Complex Coronary Lesions
Revascularization Strategies in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) and Severe Coronary Artery Disease
Evolocumab in Patients With Multivessel Coronary Disease After Acute Myocardial Infarction: A Target Trial Emulation
Cardiovascular Events Related to Treated Coronary Arteries in Stable Multivessel CAD
Surgical Versus Percutaneous Revascularization in Patients With Reduced Left Ventricular Function (STICH 3.0-NL)
For Patients With Myocardial Infarction and Multiple Vessel: Testing if Ultrasound (UFR) Can Guide All Needed Treatment in One Procedure, Avoiding a Return Hospital Visit for a Second Operation.
Safety and Effectiveness of GENOSS® DES in Patients With Multivessel Coronary Artery Disease
Functional Testing Underlying Coronary Revascularisation
Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCI
STICH3C Cardiac Magnetic Resonance Observational Study
Multivessel Balloon Occlusion to Investigate Obstructive Coronary Artery Disease and aNgina
Ticin Pilot Study: Sirolimus-Eluting Balloon for Stabilization and Regression of Non-Obstructive Coronary Plaques.
COMBINE-INTERVENE: COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVENtion to Reduce Cardiovascular Events
Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI
Robotically-assisted Minimally-invasive Direct Coronary Artery Bypass With Stenting, Randomized Against Coronary Artery Bypass Graft Surgery
The FAVOR V AMI Trial
Residual Inflammatory Risk-Guided colcHicine in Elderly Trial
Complete Revascularization Via Inferior Part-sternotomy
In-hospital Versus After-discharge Complete Revascularization
Validation of vFFR as Compared to FFR to Guide Revascularization of Non-culprit Lesions in STEMI Patients